Scarica l'app Stockscreener
16.73
0.72%
0.12
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché KROS Giù?
Forum
Previsione
Keros Therapeutics Inc Borsa (KROS) Ultime notizie
Why Keros Therapeutics Inc. stock could see breakout soonEarnings Risk Summary & Fast Moving Stock Trade Plans - mfd.ru
Keros Therapeutics: Key Catalysts and Financial Runway in Focus - AD HOC NEWS
Price-Driven Insight from (KROS) for Rule-Based Strategy - Stock Traders Daily
Y Intercept Hong Kong Ltd Lowers Holdings in Keros Therapeutics, Inc. $KROS - MarketBeat
Keros Therapeutics, Inc. $KROS Shares Sold by Federated Hermes Inc. - MarketBeat
Big Picture: What is SIDUs revenue forecastGap Up & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
Risk Report: What is the next catalyst for Keros Therapeutics IncDividend Hike & High Accuracy Trade Alerts - baoquankhu1.vn
Tech Rally: Is CleanCore Solutions Incs ROE strong enough2025 Stock Rankings & Risk Managed Trade Strategies - baoquankhu1.vn
Aug Opening: Will HUB Cyber Security Ltd. Equity Warrant outperform during market ralliesJuly 2025 WrapUp & Target Return Focused Stock Picks - baoquankhu1.vn
Keros Therapeutics vs. Dyne: Which DMD Biotech Has More Upside? - Nasdaq
Portfolio Shifts: Can NECB benefit from deglobalizationJuly 2025 Reactions & Community Driven Trade Alerts - baoquankhu1.vn
Market Wrap: What is the next catalyst for Keros Therapeutics IncAnalyst Downgrade & Capital Efficiency Focused Ideas - baoquankhu1.vn
Is KROS' KER-065 the Next Breakthrough in DMD Space? - The Globe and Mail
(KROS) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
MRKR stock up nearly 114% in 3 months: Here's what you need to know - MSN
Wall Street Analysts See a 42.78% Upside in Keros Therapeutics (KROS): Can the Stock Really Move This High? - MSN
Fund Flows: Does Keros Therapeutics Inc stock reflect fundamentalsWeekly Profit Report & Smart Investment Allocation Tips - baoquankhu1.vn
Is Keros Therapeutics Inc. backed by strong institutional buyingQuarterly Trade Summary & AI Driven Price Predictions - mfd.ru
JANX Enters Global Oncology Collaboration With BMY, Stock Rises - Nasdaq
Keros Therapeutics, Inc. (KROS) Investor Outlook: Exploring a Promising 20.76% Potential Upside - DirectorsTalk Interviews
Keros Therapeutics, Inc. (NASDAQ:KROS) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
MRKR Stock Up Nearly 114% in 3 Months: Here's What You Need to Know - Finviz
Will KROS Stock's Restructuring Efforts Reap Rewards for Investors? - sharewise.com
Axsome Therapeutics Begins Phase III Study on AXS-14 for Fibromyalgia - Finviz
KROS Stock Surges 85.6% in a Year: More Upside Potential in 2026? - sharewise.com
CG Oncology Stock Rallies Nearly 32% in a Week: Here is Why - Finviz
(KROS) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
TVTX Stock Falls as FDA Extends Review Timeline for Filspari sNDA - Finviz
Downgrade Watch: What’s the RSI of Keros Therapeutics Inc. stock2025 Performance Recap & Long-Term Safe Investment Plans - baoquankhu1.vn
TG Therapeutics Stock Rises 7% on Strong Q4 & 2025 Preliminary Results - Finviz
Aug Technicals: Is Keros Therapeutics Inc likely to announce a buybackJuly 2025 Reactions & Entry Point Confirmation Signals - baoquankhu1.vn
History Review: What are Keros Therapeutics Incs technical support levelsJuly 2025 Analyst Calls & Community Consensus Trade Alerts - baoquankhu1.vn
BEAM Outlines Key Strategic & Pipeline Goals for 2026, Stock Rises - Zacks Investment Research
MACD Signal: Whats the fair value of Keros Therapeutics Inc stock2025 Key Highlights & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
INSM Stock Jumps on 2025 Preliminary Sales, 2026 Goals Announced - Finviz
Keros Therapeutics, Inc. (KROS) Stock Analysis: Strong Revenue Growth and a 26% Potential Upside - DirectorsTalk Interviews
Will Keros Therapeutics Inc. stock outperform value stocks2025 Macro Impact & Weekly Breakout Opportunity Watchlist - Улправда
How rising interest rates impact Keros Therapeutics Inc. stockJuly 2025 Chart Watch & Verified Stock Trade Ideas - Улправда
What analysts say about Keros Therapeutics Inc stockSector Rotation Strategies & Real-Life Case Studies You Can Follow - earlytimes.in
Bank of America Securities Keeps Their Hold Rating on Keros Therapeutics (KROS) - The Globe and Mail
Keros Therapeutics (NASDAQ:KROS) Trading Down 3.3% on Analyst Downgrade - Defense World
Keros Therapeutics (NASDAQ:KROS) Cut to “Hold” at Zacks Research - Defense World
(KROS) Risk Channels and Responsive Allocation - Stock Traders Daily
Keros Therapeutics (NASDAQ:KROS) Downgraded to Hold Rating by Zacks Research - MarketBeat
Keros Therapeutics (NASDAQ:KROS) Stock Price Down 3.3%Time to Sell? - MarketBeat
Zacks.com featured highlights include AES, BorgWarner, Enersys, PG&E and Keros Therapeutics - Yahoo Finance
Short Interest in Keros Therapeutics, Inc. (NASDAQ:KROS) Drops By 16.6% - MarketBeat
5 Low Price-to-Book Stocks to Buy as 2025 Comes to a Close - Yahoo Finance
KROS or ARGX: Which Is the Better Value Stock Right Now? - sharewise.com
0.95%
0.92%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):